Walgreens Boots Alliance (NASDAQ:WBA) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com began coverage on shares of Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) in a research note issued on Sunday. The firm set a "hold" rating on the pharmacy operator's stock.

A number of other equities analysts have also recently issued reports on WBA. Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Bank of America upped their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a report on Monday, January 13th. Truist Financial dropped their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Royal Bank of Canada lifted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a report on Wednesday, January 15th. Finally, Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a "hold" rating to a "sell" rating and reduced their price objective for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $10.59.

Walgreens Boots Alliance Trading Down 0.2 %

WBA opened at $11.01 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The company's 50-day moving average is $10.95 and its 200 day moving average is $10.22. The firm has a market capitalization of $9.52 billion, a PE ratio of -1.08, a P/E/G ratio of 1.31 and a beta of 0.67. Walgreens Boots Alliance has a fifty-two week low of $8.08 and a fifty-two week high of $18.83.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. During the same period in the previous year, the business posted $1.20 EPS. The business's revenue for the quarter was up 4.1% compared to the same quarter last year. As a group, research analysts predict that Walgreens Boots Alliance will post 1.6 earnings per share for the current fiscal year.

Institutional Trading of Walgreens Boots Alliance

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Virtu Financial LLC acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth about $208,000. Westside Investment Management Inc. grew its position in shares of Walgreens Boots Alliance by 14.3% during the third quarter. Westside Investment Management Inc. now owns 11,587 shares of the pharmacy operator's stock worth $104,000 after acquiring an additional 1,454 shares during the last quarter. Wealthquest Corp acquired a new position in shares of Walgreens Boots Alliance in the 3rd quarter valued at $130,000. Wilmington Savings Fund Society FSB purchased a new stake in Walgreens Boots Alliance in the 3rd quarter valued at $92,000. Finally, Franklin Resources Inc. boosted its stake in Walgreens Boots Alliance by 54.4% during the 3rd quarter. Franklin Resources Inc. now owns 321,425 shares of the pharmacy operator's stock worth $2,893,000 after purchasing an additional 113,242 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.